Sponsor study identifier
observational
1,200
2 countries
17
Study Start
June 2004
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
April 2005
Actual (reported)Study Completion
April 2005
Actual (reported)A number of factors influence HIV-positive adolescents' acceptance of and willingness to continue taking anti-HIV medicines. These factors include mental health and substance abuse issues, barriers such as lack of medical insurance, and cognitive-behavioral barriers (such as a person's impression of the impact of the medicines on his/her health and a person's sense of his/her ability to continue taking the medications prescribed). The purpose of this study is to use a survey to determine how common specific barriers are that prevent HIV positive adolescents from taking their anti-HIV medicines and if those barriers cluster together. The information collected will be used to develop and validate a schema for classifying HIV medication adherence by barriers to adherence or clusters of barriers to adherence. This classification schema could then be used in the development of interventions that better meet the needs of HIV-infected youth.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
April 2005
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
June 2004
Date type not reportedThis date has not been verified as actual or estimated.
March 28, 2005
Actual (reported)March 29, 2005
Actual (reported)April 2005
Actual (reported)April 2005
Actual (reported)The study population will consist of HIV-infected youth who are eligible for antiretroviral therapy (ART) based on the US Public Health Service (PHS) guidelines and have been offered and/or prescribed HAART by their healthcare provider. Subjects aged 12 through 24 years old will be recruited from youth engaged in care at the fifteen ATN clinical sites located across the United States and in Puerto Rico. Youth engaged in care at selected non- ATN clinic centers will also be offered the opportunity to participate in this study.
Children's Hospital of Los Angeles
Los Angeles, California, 90027, United States
University of California at San Diego
San Diego, California, 92103, United States
University of California at San Francisco
San Francisco, California, 94143, United States
Children's National Medical Center
Washington D.C., District of Columbia, 20010, United States
Children's Diagnostic and Treatment Center
Fort Lauderdale, Florida, 33316, United States
University of Miami
Miami, Florida, 33101, United States
University of South Florida
Bret Rudy, MD
Children's Hospital of Philadelphia
1,200 participants (actual enrollment reported by the registry).
First Submitted
March 28, 2005
First Posted
March 29, 2005
Study Start
June 2004
Date type not reportedThis date has not been verified as actual or estimated.
Healthy Choices to Promote Health and Reduce Risk in HIV-Infected Youth
Contact the study team to confirm eligibility.
Tampa, Florida, 33606, United States
Stroger Hospital of Cook County
Chicago, Illinois, 60612, United States
Tulane University
New Orleans, Louisiana, 70112, United States
University of Maryland Medical School
Baltimore, Maryland, 21204, United States
Johns Hopkins Hospital
Baltimore, Maryland, 21224, United States
Childrens Hospital Boston
Boston, Massachusetts, 02115, United States
Weill Medical College of Cornell University-New York Presbyterian Hospital
New York, New York, 10021, United States
Mount Sinai Hospital
New York, New York, 10128, United States
Montefiore Medical Center
The Bronx, New York, 10467, United States
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, 19104, United States
University Pediatric Hospital
San Juan, 00936, Puerto Rico
Primary Completion
April 2005
Actual (reported)Study Completion
April 2005
Actual (reported)Last Updated
March 1, 2017
Record last verified: 2016-02
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: